Medicine News and Research

RSS

Stem cell therapy used to fight amyotrophic lateral sclerosis

A team of Utahns is collaborating on a stem cell therapy to fight amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease.

21 Apr 2009

Chronic lymphocytic leukemia linked to seven different gene variants

A national team of researchers led by Mayo Clinic has found that patients with chronic lymphocytic leukemia (CLL) are more likely to have similar DNA changes or variants in up to six genes, compared to people who do not have the cancer.

21 Apr 2009

New drug to target tumor cells and blood vessels

Researchers at the University of Southern California have identified a new drug compound that appears to target tumor cells and surrounding blood vessels without the negative side effects typically associated with Cox-2 inhibitors.

21 Apr 2009

Psoriasis increases risk for developing diabetes and hypertension in women

Women with psoriasis appear to have an increased risk for developing diabetes and hypertension (high blood pressure), according to a report in the April issue of Archives of Dermatology.

21 Apr 2009

Brain manufactures proteins that act like marijuana

U.S. and Brazilian scientists have just proven that one of Bob Dylan's most famous lines - "everybody must get stoned" - is correct.

20 Apr 2009

Potential new target for treatment of Rett syndrome

A research collaboration between Australia and Israel has identified a genetic variation that influences the severity of symptoms in Rett syndrome.

20 Apr 2009

News coverage of trans fat prompts shoppers to avoid certain products

News coverage about the harmful effects of trans fat, combined with labeling information, may influence consumers' short-term purchases of foods high in trans fat, but is not enough to prompt shoppers to avoid these potentially artery-clogging purchases over the long term, according to a study in the May issue of the American Journal of Preventive Medicine.

20 Apr 2009

Removal of ovaries during hysterectomy increases risk of death, outweighs benefits

Results of a landmark study led by a doctor at John Wayne Cancer Institute at Saint John's Health Center raises serious questions about the long-term survival benefits of removing a woman's ovaries during routine hysterectomy.

20 Apr 2009

NCI plan to speed cancer research

At the American Association for Cancer Research 100th Annual Meeting 2009 in Denver, National Cancer Institute (NCI) Director John E. Niederhuber, M.D., announced major details, such as funding more grants, development of a platform for personalized cancer care, and an accelerated cancer genetics program, that will move cancer research forward in this new economic environment.

20 Apr 2009

New information on molecular biology of KRas protein

KRas is one of the usual suspects in cancer. It is a protein that is mutated in 30% of human tumors and has been implicated in the regulation of many cell signalling pathways.

20 Apr 2009

New insights into transcription factors in human cells

Bioinformatics researchers from UC San Diego just moved closer to unlocking the mystery of how human cells switch from "proliferation mode" to "specialization mode."

20 Apr 2009

Human foetal stem cells can effectively be used to treat back leg ischaemic ulcers

Treatment of chronic wounds is a continuing clinical problem and socio-economic burden with diabetic foot ulcers alone costing the NHS £300 million a year.

20 Apr 2009

Grouping muscles to make controlling limbs easier

With more than 30 muscles in your arm, controlling movement -- whether it's grasping a glass or throwing a baseball -- is a complex task that potentially takes into account thousands of variables.

20 Apr 2009

Genetic source of rare cancer pleuropulmonary blastoma discovered

The search for the cause of an inherited form of a rare, aggressive childhood lung cancer has uncovered important information about how the cancer develops and potentially sheds light on the development of other cancers.

20 Apr 2009

First noninvasive technique to accurately predict mutations in human brain tumors

Donald O'Rourke, MD, Associate Professor of Neurosurgery at the University of Pennsylvania School of Medicine and colleagues, were able to accurately predict the specific genetic mutation that caused brain cancer in a group of patients studied using magnetic resonance imaging (MRI).

20 Apr 2009

Researchers identify mechanism by which an anti-TNF therapy impairs host defense against tuberculosis

The life of many individuals with inflammatory diseases such as rheumatoid arthritis has been dramatically improved by treatment with drugs that target the protein TNF, so called anti-TNF therapies.

20 Apr 2009

Effect of 18F-FDG PET/CT in esophageal cancer patients with early recurrence lesions

In the initial staging of esophageal cancer, preoperative PET scan may be useful in detecting additional cases of metastatic disease before costly and toxic definitive therapy.

20 Apr 2009

Discovery of key processes in the brain that control perception of emotional events

Research performed by Nicole Lauzon and Dr. Steven Laviolette of the Schulich School of Medicine & Dentistry at The University of Western Ontario has found key processes in the brain that control the emotional significance of our experiences and how we form memories of them.

20 Apr 2009

Complications, death rates similar at bariatric surgery centers of excellence, other hospitals

Patients who undergo bariatric surgery at hospitals designated as centers of excellence do not appear to have lower mortality rates or lower rates of complications than those whose procedures are performed at other hospitals, according to a report in the April issue of Archives of Surgery, one of the JAMA/Archives journals.

20 Apr 2009

Ardea Biosciences announces positive results from a phase 1 study of lead candidate for hyperuricemia and gout

Ardea Biosciences, Inc. has announced positive results from a Phase 1 study in normal, healthy volunteers of RDEA594, its lead product candidate for the treatment of hyperuricemia and gout, and a pilot Phase 2a proof-of-concept study in gout patients of RDEA594's prodrug, RDEA806 (RDEA806 is converted to RDEA594 in the body).

20 Apr 2009

Medicine News and Research

Stem cell therapy used to fight amyotrophic lateral sclerosis

Chronic lymphocytic leukemia linked to seven different gene variants

New drug to target tumor cells and blood vessels

Psoriasis increases risk for developing diabetes and hypertension in women

Brain manufactures proteins that act like marijuana

Potential new target for treatment of Rett syndrome

News coverage of trans fat prompts shoppers to avoid certain products

Removal of ovaries during hysterectomy increases risk of death, outweighs benefits

NCI plan to speed cancer research

New information on molecular biology of KRas protein

New insights into transcription factors in human cells

Human foetal stem cells can effectively be used to treat back leg ischaemic ulcers

Grouping muscles to make controlling limbs easier

Genetic source of rare cancer pleuropulmonary blastoma discovered

First noninvasive technique to accurately predict mutations in human brain tumors

Researchers identify mechanism by which an anti-TNF therapy impairs host defense against tuberculosis

Effect of 18F-FDG PET/CT in esophageal cancer patients with early recurrence lesions

Discovery of key processes in the brain that control perception of emotional events

Complications, death rates similar at bariatric surgery centers of excellence, other hospitals

Ardea Biosciences announces positive results from a phase 1 study of lead candidate for hyperuricemia and gout

Everything there is to know about biosimilars eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News